HomeNewsOpinionIs there a market upside to China’s COVID-19 lockdowns?

Is there a market upside to China’s COVID-19 lockdowns?

Policy makers have the ammunition to boost stocks as they counter an economic slowdown

April 13, 2022 / 08:40 IST
Story continues below Advertisement
Foreign Ministry spokesperson Zhao Lijian on April 10 said China had “lodged solemn representations with the U.S." after the State Department advised Americans to reconsider traveling to China due to “arbitrary enforcement” of local laws and COVID-19 restrictions, particularly in Hong Kong, Jilin province and Shanghai. U.S. officials cited a risk of “parents and children being separated.” China was “strongly dissatisfied with and firmly opposed to the U.S. side’s groundless accusation against China’s epidemic response,” Zhao said. (Image: AP)
Foreign Ministry spokesperson Zhao Lijian on April 10 said China had “lodged solemn representations with the U.S." after the State Department advised Americans to reconsider traveling to China due to “arbitrary enforcement” of local laws and COVID-19 restrictions, particularly in Hong Kong, Jilin province and Shanghai. U.S. officials cited a risk of “parents and children being separated.” China was “strongly dissatisfied with and firmly opposed to the U.S. side’s groundless accusation against China’s epidemic response,” Zhao said. (Image: AP)

Bloomberg

The lockdown in Shanghai, accompanied by media accounts of food shortages and unreported deaths, are evoking painful recollections of January 2020 and the central city of Wuhan, where COVID-19 first broke out. For investors, the memory will also include the economic stimulus that China unleashed then to fight off a recession — as well as the bull market that ensued.

Story continues below Advertisement

That may explain why China’s main stock indexes have not sunk below their mid-March low, even as the number of COVID-19 cases soared. Counterintuitively, since the initial outbreak in 2020, index returns were positively — not negatively — correlated with the number of cases, according to Goldman Sachs Group Inc.

By now, China has built a track record of containing COVID-19 outbreaks. As such, investors are looking through the short-term economic losses, and focusing instead on the policy goodies that Beijing is willing to hand out.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show